SMC Approves Exjade® - No More Needles In Scotland - Good News For People With Sickle Cell Disease And Thalassaemia

... Novartis today welcomed the Scottish Medicines Consortium's acceptance of deferasirox (Exjade®) for use within NHS Scotland for the treatment of iron overload associated with the treatment of rare acquired or inherited anaemias. The Scottish Medicines Consortium (SMC) provides advice to the NHS in Scotland about the use of all newly licensed medicines. [click link for full article] ...